Primary non-response in inflammatory arthritis treated with biologics and targeted therapies in daily clinical practice
This study provides support to consider swapping a better alternative rather than cycling after primary non-response.
Authors
- Esther Toledano (ORCID: https://orcid.org/0000-0003-3306-1398)
- Leticia León (ORCID: https://orcid.org/0000-0001-7142-0545)
- Benjamín Fernández‐Gutiérrez (ORCID: https://orcid.org/0000-0002-6126-8786)
- Gloria Candelas (ORCID: https://orcid.org/0000-0001-7759-5127)
- Lydia Abásolo (ORCID: https://orcid.org/0000-0001-8152-0478)
- María Rodríguez‐Laguna
- D. Freites (ORCID: https://orcid.org/0000-0002-0966-2778)
- Cristina Martínez
Institutions
- Universidad Complutense de Madrid (ES)
- Hospital Clínico San Carlos (ES)
- Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
Publication Details
- Journal
- Therapeutic Advances in Musculoskeletal Disease
- Published
- 2025-03-30
- DOI
- https://doi.org/10.1177/1759720x251325665
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- European Regional Development Fund